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Attention deficit/hyperactivity disorder (ADHD), autism spectrum disorder (autism), and 
schizophrenia, are highly heritable neurodevelopmental disorders, affecting the lives of many 
individuals. To improve prevention and treatment, it is important to increase our understanding of 
how the polygenic risk for neurodevelopmental disorders manifests during childhood in boys and 
girls. 
Method  
Polygenic risk scores (PRS) for ADHD, autism and schizophrenia were calculated in a sub-sample of 
15 205 children from the Norwegian Mother, Father and Child Cohort Study (MoBa).  Mother-
reported traits of repetitive behavior, social communication, language and motor difficulties, 
hyperactivity and inattention were measured in children at 6 and 18 months, 3, 5 and 8 years. Linear 
regression models in a multi-group framework were used to investigate associations between the 
three PRS and dimensional trait measures in MoBa, and sex was used as a grouping variable.  
Results  
Before the age of 2, PRS associations were found with language difficulties, inattention and 
hyperactivity, mostly increasing in strength up to 8 years. PRS for autism was associated with motor 
difficulties as early as 6 months. By 8 years, all measured neurodevelopmental traits had shown 
some association with at least one neurodevelopmental PRS. In general, genetic risk manifested 
similarly in boys and girls. Associations were, however, stronger in girls for language difficulties and 
ADHD PRS at 8 years. The association between schizophrenia PRS and inattention was found in girls 
only at 18 months. For autism PRS, associations with social communication difficulties at 18 months, 









Genetic risk for neurodevelopmental disorders manifests early in childhood and broadly across behavioral 
measures of neurodevelopment. Manifestations may be sex specific in some domains, but these findings 
need to be replicated.  
 
Keywords: Polygenic risk score, neurodevelopmental disorders, ADHD, autism, schizophrenia, 
repetitive behavior, social communication, language and motor difficulties, hyperactivity, 
inattention, MoBa 








Neurodevelopmental disorders (NDDs) are characterized by childhood-onset impairments in 
developmental domains such as language, motor skills, communication and social interaction, 
behavioral flexibility, and regulation of attention, activity and impulses (Association, 2013; Thapar, 
Cooper, & Rutter, 2017).  Common neurodevelopmental disorders include attention 
deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (autism) (Thapar et al., 2017). 
Schizophrenia, although typically diagnosed in adolescence or early adulthood, is commonly 
associated with developmental difficulties in childhood and therefore also considered to be a 
neurodevelopmental disorder (Riglin et al., 2017).  
 
ADHD, characterized by inattention and/or hyperactivity-impulsivity, is the most common behavioral 
disorder in childhood, affecting approximately 4-5% of children worldwide and usually diagnosed 
around age 6 years (Kessler et al., 2007; G. Polanczyk, De Lima, Horta, Biederman, & Rohde, 2007; G. 
V. Polanczyk, Willcutt, Salum, Kieling, & Rohde, 2014; Visser et al., 2014). Autism, characterized by 
communication and social interaction impairments along with restricted and repetitive behavior 
(Grove et al., 2019; Sullivan, Daly, & O'donovan, 2012) affects about 1.5% of children in high-income 
countries (Lyall et al., 2017), and is diagnosed at a median age of 4 years (Baio et al., 2018). 
Schizophrenia, characterized by long-standing delusions and hallucinations, disorganized speech or 
behavior (Sullivan et al., 2012), affects about 1% of the population in adulthood (Segal, 2010). ADHD 
and autism are more prevalent in males compared to females (Surén et al., 2012; Willcutt, 2012). For 
schizophrenia, although the prevalence is similar, males have an earlier onset than females (Li, Ma, 
Wang, Yang, & Wang, 2016). Mechanisms underlying sex differences are largely unknown, and 
recognition and diagnosis might be biased towards male manifestations (May, Adesina, McGillivray, 
& Rinehart, 2019). Although ADHD, autism and schizophrenia are categorically defined for clinical 
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purposes, they can also be viewed as the extremes of continuous trait dimensions found in the 
general population (Rössler, 2013).  
 
Neurodevelopmental disorders like ADHD, autism and schizophrenia are highly heritable (70-90%) 
and etiologically complex, involving a large number of potentially overlapping genetic and 
environmental risk factors (Burmeister, McInnis, & Zöllner, 2008; Faraone & Larsson, 2019; Homberg 
et al., 2016; Mulligan et al., 2009; Sullivan et al., 2018; Sullivan et al., 2012). 
 
The genetic influence on neurodevelopmental disorders includes both common (present in >1% of 
the population) and rare variants. Genome wide association studies (GWAS) indicate that a 
substantial part of the genetic liability to neurodevelopmental disorders are conferred by common 
single nucleotide polymorphisms (SNPs) distributed across the genome (Grove et al., 2019; Sullivan 
et al., 2012). Common SNPs have individually low impact, but together explain a substantial 
proportion of the risk. 
 
Genetic risk for neurodevelopmental disorders might manifest in sub-clinical symptoms in the 
general population. Prospective and longitudinal general population cohorts, like the Norwegian 
Mother, Father and Child Cohort Study (MoBa), represent a unique framework for studying 
manifestations of genetic risk (Robinson, Shaver, & Wrightsman, 2013). 
 
Only a few studies have used PRS to examine manifestations of genetic risk for neurodevelopmental 
disorders in early childhood (Jansen et al., 2018; Martin, Hamshere, Stergiakouli, O’Donovan, & 
Thapar, 2014; Nivard et al., 2017; Riglin et al., 2017). In the Avon longitudinal study of parents and 
children cohort (ALSPAC), PRS for schizophrenia predicted impairments of language and social 
communication at age 7-9 years (Riglin et al., 2017), and PRS for ADHD were associated with 
hyperactivity and inattention at 7-9 years (Martin et al., 2014). A lack of measures of 
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neurodevelopmental traits prior to the age of four years has been a limitation for multiple studies. 
Inclusion of earlier measures is needed to increase our understanding of when, during development, 
genetic risk for various neurodevelopmental disorders is expressed in observable traits. To improve 
prevention and treatment, the knowledge gap on developmental influences on the phenotypic 
manifestations of genetic risk for psychiatric disorders is important to address (Sullivan et al., 2018).  
 
Previous studies have focused on the genetic risk of specific disorders (Burmeister et al., 2008; 
Faraone & Larsson, 2019; Homberg et al., 2016; Sullivan et al., 2018; Sullivan et al., 2012) often using 
diagnostic measures in older children as outcomes. Where trait measures of neurodevelopment have 
been studied, they have rarely been measured in children younger than 4 years old. We examined 
when and how genetic risk for ADHD, autism and schizophrenia is expressed in neurodevelopmental 
traits (repetitive behavior, social communication difficulties, language and motor difficulties, 
hyperactivity and inattention) from 6 months up to 8 years, and if they are expressed differently 
between boys and girls.  
Methods 
Sample 
We used children from the Norwegian Mother, Father and Child Cohort Study (MoBa) as our sample. 
MoBa is a longitudinal pregnancy cohort including about 114 500 children, their mothers and fathers 
(Magnus et al., 2016; Magnus et al., 2006). Blood samples were collected from the children’s 
umbilical cord at birth (Paltiel et al., 2014). The genotyping, imputation and quality control is 
described in the supplementary material. Genotype data was available for a sub-sample of 15 205 of 
the children (48.9% girls). In MoBa, pregnant women were recruited from 1999 to 2008. The women 
consented to participation in 40.6% of the pregnancies. Written informed consent was obtained from 
all participants upon recruitment. The initial data collection was based on a license from the 
Norwegian Data Protection Agency and approval from The Regional Committee for Medical Research 
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Ethics. The MoBa cohort is currently regulated by the Norwegian Health Registry Act. The current 
study was approved by the Regional Committees for Medical and Health Research Ethics (2016/1702) 
and has undergone a Data Protection Impact Assessment.  
Measures 
Mother-reported questionnaire data was available from when children were aged 6 and 18 months, 
3, 5, and 8 years. The questionnaires included several dimensional measures of traits related to 
neurodevelopment. Version 12 of the quality assured MoBa data files were used to conduct the 
analyses. 
 
Social communication difficulties and repetitive behavior were measured using items from the Ages 
and Stages Communication scale at 6 months (only social communication) (Richter & Janson, 2007), 
the Modified Checklist for Autism in Toddlers (M-CHAT) (Baron-Cohen, Allen, & Gillberg, 1992; 
Robins, Fein, Barton, Green, & disorders, 2001) at 18 months and the Social Communication 
Questionnaire (SCQ) (Rutter, Bailey, & Lord, 2003) at 3 and 8 years. When the children were 5 years 
old, the mothers reported on a short version (Ronald, Happé, Plomin, & Psychiatry, 2008) of the 
Childhood Autism Spectrum Test (CAST; formerly named Childhood Asperger Syndrome Test) (Scott, 
Baron-Cohen, Bolton, & Brayne, 2002), which includes items similar to the SCQ and M-CHAT.  
 
Inattention and hyperactivity/impulsivity were assessed using the Diagnostic and Statistical Manual 
of Mental Disorders (DSM)-oriented ADHD problems scale of the Child Behavior Check List (CBCL) 
(Achenbach, Dumenci, & Rescorla, 2001) at 18 months and 3 years, the revised Conner’s Parent 
Rating Scale (CPRS-R) (Kumar & Steer, 2003) at 5 years, and the full Parent/Teacher Rating Scale for 
Disruptive Behavior Disorders (RS-DBD) (Silva et al., 2005) at 8 years. 
 
Language difficulties were measured at 18 months, 3 and 5 years using the Ages and Stages 
Questionnaire (ASQ). The ASQ has been found to be an effective screening tool for developmental 
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difficulties (Richter & Janson, 2007). At 8 years, the Children’s Communication Checklist-2 (CCC-2) 
(Bishop, 2003) was used to identify language difficulties. Motor difficulties were measured at 6 and 
18 months, and 3 years using ASQ, and at 5 years using Children’s Development Inventory (CDI) 
(Ireton, 1992). 
Statistical analyses 
Polygenic risk scores (PRS) were generated, using PRSice2 (Choi & O'Reilly, 2019), for each child in 
our analytic sample, based on summary statistics from European samples from the most recent 
Psychiatric Genomic Consortium (PGC) GWAS for each disorder; ADHD (20 183 cases and 35 191 
controls) (Demontis et al., 2019); autism (18 381 cases and 27 969 controls) (Grove et al., 2019), and 
schizophrenia (36 989 cases and 113 075 controls) (Ripke et al., 2014). PRS combines the effects of 
common SNPs observed in large-scale GWAS to capture the cumulative effect of risk alleles in an 
individual (Wray et al., 2014). All summary statistics from PGC were subject to quality control 
including filtering for minor allele frequencies (MAF>1%) and INFO threshold>0.8. We used PRS built 
on a range of p value thresholds (<5e-8, <1e-6, <1e-4, <0.001, <0.01, <0.05, <0.1., <0.2, <0.5. and 1) 
for inclusion of SNPs with progressively weaker associations with the disorders in the original GWAS, 
and assessed the consistency of results across thresholds as part of sensitivity checking. In our main 
figures and tables, we present results of PRS made at the p-value threshold <0.05, in line with other 
studies (Riglin et al., 2017), but results at all thresholds are presented in the supplementary material 
as well as tables of which p-value threshold that explained most variance in the outcome (see 
supplementary table S3, S5 and S7).  
 
R version 3.4.4 was used for linear regression models in the lavaan-package (Rosseel, 2012) to assess 
associations between the PRS for the three neurodevelopmental disorders and dimensional 
measures of development at all ages (for one PRS at the time). The correlations between PRS 
(calculated at the p <0.05 threshold) were 0.17 between ADHD and autism PRS (95% CIs: 0.16-0.19); 
0.07 between ADHD and schizophrenia (95% CIs: 0.05-0.08); and 0.01 between autism and 
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schizophrenia (95% CIs: -0.01-0.03). PRS and outcome measures were standardized to zero mean and 
unit variance prior to analyses. Sex differences were investigated by including sex as a grouping 
variable in a multi-group framework.  
 
In order to account for multiple testing, we corrected the critical p-value threshold for the number of 
effective tests run (Bonferroni correction). To determine the number of effective tests, we ran a 
principal component analysis on all the 25 outcome measures (Leppert et al., 2019). The number of 
tests was defined as the number of principal components explaining 80% variance, which was 16. A 
p-value of 0.05 will therefore be represented by a corrected p-value of 0.0031 (0.05/16). 
Results 
Descriptive statistics for the neurodevelopmental trait scales are presented in Table 1. For 
information not divided by sex, including Cronbach’s alpha for each scale, see supplementary. For 




Polygenic risk score for ADHD 
The associations between ADHD PRS and neurodevelopmental traits at different time points and in 
boys and girls are shown in Figure 1. There was a general pattern of increasing associations with age, 
and most of the associations did not differ across the sexes. Genetic risk for ADHD showed a pattern 
of positive association with repetitive behavior across age, although strong evidence of association 
was only observed at 3 years (β = 0.024, CI = 0.003-0.045). There was also strong evidence of a 
positive association with language difficulties at 5 years for both sexes (β = 0.047, CI = 0.022-0.071) 
and at 8 years for girls (β = 0.061, CI = 0.028-0.093). We did not observe any robust evidence of 
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association with motor difficulties. Genetic risk for ADHD was also robustly associated with increased 




Polygenic risk score for autism 
The associations between autism PRS and neurodevelopmental traits across age and sex are shown 
in Figure 2. There is a general pattern of positive association with neurodevelopmental difficulties, 
meaning that those with more autism-associated SNPs tended to have higher scores on these traits. 
The autism PRS was positively associated with repetitive behavior in both sexes at 8 years (β = 0.028, 
CI = 0.002-0.054). PRS for autism showed a positive association with social communication difficulties 
in boys at 18 months (β = 0.035, CI = 0.011-0.061), and in both sexes at 5 years (β = 0.052, CI = 0.014-
0.089). PRS for autism also showed a consistent association with language and motor difficulties, 
although strong evidence of associations with motor difficulties was only observed in boys at age 5 
years (β = 0.052, CI = 0.020-0.084). PRS for autism was associated with hyperactivity at 5(β = 0.028, CI 





Polygenic risk score for schizophrenia 
The associations between schizophrenia PRS and neurodevelopmental traits across age and sex are 
shown in Figure 3. We observed no strong evidence of associations between the schizophrenia PRS 
and neurodevelopmental difficulties from infancy to mid-childhood in MoBa. However, there was 
weaker evidence for association with repetitive behavior at 18 months (β = 0.019, CI = 0.001-0.038) 
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and 3 years (β = 0.027, CI = 0.006-0.047), language difficulties at 3 years (β = 0.025, CI = 0.003-0.048) 





Supplementary Online tables S2-S4 show the explained variance on the p-value threshold 0.05 for 
both males and females on all neurodevelopmental traits. Supplementary Online Figure S1 shows the 
correlation between neurodevelopmental traits. Supplementary Online Figures S2-S10 display the 
associations of the 6 developmental traits of repetitive behavior, social communication difficulties, 
language and motor difficulties, hyperactivity and inattention at 10 different p-value thresholds for 
the PRS.  
Discussion 
Our aim was to identify early manifestations of polygenic risk for ADHD, autism, and schizophrenia in 
children between 6 months and 8 years in the general population. This is important so potential 
mediators and moderators of risk can be examined, and to determine the usefulness of polygenic risk 
scores for prediction of neurodevelopmental difficulties. We found that polygenic risk was associated 
with developmental traits as early as 6 months. Previous studies have not been able to investigate 
such associations at this young age. Before the age of two each PRS showed an association with at 
least one of the neurodevelopmental traits, and the autism PRS did show an association with all 
neurodevelopmental traits at least once between the age of 6 months to 8 years. It is important to 
note that, due to limited number of available measures, these analyses are specific for given time 
points, and not analyzed as developmental trajectories. The main pattern seems to be that the 
polygenic risk manifest similarly in boys and girls, but we did observe some sex differences, 
particularly a stronger association between language difficulties and ADHD PRS in girls than in boys, 
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and a stronger association between hyperactivity and inattention and ADHD PRS, and motor 
difficulties and autism PRS in boys as compared to girls.  
 
To our knowledge, this is the first study showing that ADHD PRS may be associated with repetitive 
behavior in early childhood. However, observational studies suggest that children with an ADHD 
diagnosis score higher on measures of repetitive behavior (Cooper, Martin, Langley, Hamshere, & 
Thapar, 2014), especially at younger ages (Martin et al., 2014). Although the ADHD PRS associations 
with repetitive behavior were relatively weak, they appeared consistent across age and sensitivity 
analyses with varied SNP inclusion criteria. 
 
Our results suggest that risk alleles for ADHD may contribute to language difficulties in girls at 8 
years. This is in line with previous studies (Martin et al., 2014) where they found an associaction 
between ADHD PRS and pragmatic language, but they did not investigate sex differences.  
 
Our results suggest that associations between ADHD polygenic risk and hyperactivity and inattention 
in the general population are robust as early as age 18 months and persist and strengthen with age 
to mid-childhood. This supports and extends previous findings from other cohorts (Martin et al., 
2014). The only identified sex difference was at 18 months, with boys showing a positive association 
with both hyperactivity and inattention. There are more boys being diagnosed with ADHD than girls, 
and these traits are core diagnostic criteria for this disorder.  
 
We found some evidence of an association between autism PRS and repetitive behavior at age 8, 
which is a core feature of autism (APA, 2013). We also found some evidence of associations between 
polygenic risk for autism and social communication difficulties in the general population, which is in 
line with previous studies in mid-childhood (age 8: St Pourcain et al. (2018); age 6: Takahashi et al. 
(2020)). We were able to examine the association at younger ages and found an association for boys 
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at 18 months between autism PRS and social communication difficulties, and at 5 years for both 
sexes, supporting St Pourcain et al. (2018) study that social communication difficulties may manifest 
at an early age.  
 
We identified an association between autism PRS and language difficulties across all ages, which 
indicates that polygenic risk for autism contributes to language difficulties across early and mid-
childhood development.  
 
For schizophrenia PRS, we observed only weak evidence of association with repetitive behavior at 18 
months and 3 years, language difficulties at age 3 and 8 years, and attention problems at age 18 
months for girls. A number of possible explanations exist for why we did not identify strong evidence 
of associations between the schizophrenia PRS and childhood neurodevelopmental measures. First, 
we examined trait associations at younger ages than most previous studies. Since schizophrenia has a 
late onset, signs of polygenc risk for schizophrenia may manifest at a later stage. Associations found 
in other cohorts from mid-childhood (e.g., Nivard et al. (2017); Riglin et al. (2017); St Pourcain et al. 
(2018)) have been of small magnitude, although increasing somewhat in strength with age. Thus, our 
power to detect earliest signs of the schizphrenia PRS manifestations might be low. Second, genetic 
risk for schizophrenia may be expressed in other phenotypes not captured by current measures. 
Genetic variants showing an association with schizophrenia may only weakly index the risk for some 
phenotypic measures, and may more strongly reflect genetic risk for other characteristics of the 
disorder, such as negative symptoms.  
Limitations 
The study has some limitations. Some are limitations inherent to analyses using PRS based on current 
GWAS including small effect sizes, GWAS sample sizes and ascertainment methods (Demontis et al., 
2019; Grove et al., 2019; St Pourcain et al., 2018). Rare genetic variants are not captured by GWAS, 
so we are only able to examine associations with common variants. Some limitations were specific to 
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our study. First, we used a strict multiple testing correction which may have resulted in failure to 
identify some true effects. However, we saw several effects pass this strict threshold, meaning we 
are able to have confidence in the robustness of these findings. Second, there are demographic 
differences between the discovery GWAS samples and our sample. The discovery sample consists of 
both children and adults with a diagnosis. There is an ongoing discussion about whether childhood 
and adult onset ADHD is actually the same disorder (Rovira et al., 2020). If not, the PRS for ADHD 
would yield different results than if the discovery sample was based purely on children. Third, despite 
the use of one of the largest population-birth cohorts worldwide, the current subsample may not be 
adequately powered to identify small effects in some domains. Fourth, as with all longitudinal 
studies, MoBa is subject to attrition (Nilsen et al., 2013). Previous studies have shown that predictors 
of attrition include presence of behavioral difficulties, such as ADHD, in the study child (Wolke et al., 
2009). Missing data in the cohort could lead to bias in our estimates, and selective missingness may 
lead to underrepresentation of participants with high genetic risk for a neurodevelopmental 
disorder, or an underestimation of association as it would be likely to reduce the correlation between 
the PRS and the neurodevelopmental traits.  
Conclusions 
To our knowledge, our study is the first to investigate manifestations of genetic risk for multiple 
neurodevelopmental disorders in a general population sample of children as young as six months of 
age. The results show that genetic risk for clinically diagnosed neurodevelopmental disorders is 
detectable in neurodevelopmental traits in the general population at an early age. It is relatively 
broadly expressed, and appears predominantly consistent across sex, with some exceptions that 
should be further investigated. Even larger population-based longitudinal studies with both genetic 
data and robust and consistent measures of neurodevelopmental traits are required to reliably 
detect how genetic risk for neurodevelopmental disorders are expressed from infancy through 
childhood and adulthood.  
14 
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• Liability to neurodevelopmental disorders is partially underpinned by incremental effects of 
many common genetic variants 
• These variants are also associated with a range of neurodevelopmental traits in the general 
population across childhood and sex 
• Where we found an association there is a vulnerability that needs to be attenuated by 
clinicians in meetings with children who show this behavior and might have a genetic risk. 
Our results narrow the knowledge gap on how genetic risk for neurodevelopmental disorders 
manifest manifests both early in development and broadly across a range of domains, with 
some specificity for boys and girls.  
• Some behavior manifest different in boys and girls, and this should be given attention by 
clinicians when examining the child 
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